Tag: COAPT
EXPAND registry outcomes of new MitraClip devices in line with COAPT
Jörg Hausleiter (Munich, Germany) talks to Cardiovascular News about the one-year findings of ...
Early quality of life increases or benefits in COAPT translate to better long-term clinical outcomes
Early improvement in health status for patients in the COAPT trial who had transcatheter mitral ...
TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective
The MitraClip device (Abbott) continues to demonstrate safety and efficacy at three years in pat...
ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip
At the European Society of Cardiology Congress (ESC 2019; 31 August–4 September, Paris, France),...
EuroPCR 2019: PCR issues statement on edge-to-edge repair in heart failure management with secondary MR
PCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) issued a s...
Reconciling the contrasting findings on MitraClip, and implications for the management of functional mitral regurgitation
Last year, the first two randomised controlled trials (RCT) looking at percutaneous edge-to-edge...
TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations
Delegates at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, ...
